Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services
aveta.com

See what CB Insights has to offer

Stage

Unattributed VC | Alive

Total Raised

$100M

Last Raised

$100M | 22 yrs ago

About Aveta

Aveta Inc. is a health organizations in the United States, caring for more than 220,000 Medicare beneficiaries and 320,000 commercial members. Aveta specializes in building provider networks and management service organizations that emphasize integration and coordination of healthcare. Aveta is headquartered in Ft. Lee, New Jersey and has operations in Puerto Rico, California and Illinois.

Aveta Headquarter Location

173 Bridge Plaza North

Fort Lee, New Jersey, 07024,

United States

201-969-2300

Latest Aveta News

Meditrina Expands Hysteroscopic Tissue Resection Product Portfolio With The Release Of The New Aveta® Office Suite

Jul 9, 2021

Meditrina Expands Hysteroscopic Tissue Resection Product Portfolio With The Release Of The New Aveta® Office Suite SAN JOSE, Calif., July 9, 2021 /PRNewswire/ -- Meditrina Inc. Author: Jul 9, 2021 2:58 PM EDT SAN JOSE, Calif., July 9, 2021 /PRNewswire/ -- Meditrina Inc. announces the market release of their single-use Aveta Opal Hysteroscope and disposable Aveta Auto Resecting Device for removing soft endometrial tissue such as uterine polyps in an office setting, without the need for fluid management. The Aveta Opal HD Hysteroscope has the smallest insertion profile at 4.6mm featuring a 3.0mm working channel optimized for use with the 2.9 mm OD Aveta Auto Resecting Device, which are now part of the newly introduced Aveta office suite product portfolio. The Aveta Opal and Aveta Coral are the only commercially available hysteroscopes that have the capability to resect both fibroids and polyps without the need for a 5.5mm sheath and increased dilatation, ideal for post-menopausal patients and those with a stenotic cervix. The Aveta Auto sets itself apart from existing devices on the market due to its internal handle mechanics. Situated inside the handle is a motorized internal fluid management suction pump and resection drive. Additionally, there is an integrated tissue specimen container attached to the device for convenient pathology collection. The automated tissue removal is faster than anything else offered commercially and eliminates fatigue due to manual hand squeezing for tissue resection. Dissatisfaction with manual devices has resulted in costly blades being utilized to complete cases, therefore, decreasing profitability. "OBGYN's have long been searching for a platform that allows them to fully integrate "see and treat" methodology since the 58558 code was revalued by CMS. "See and treat" has proven cost savings to both patient and buyer. Upfront investment and inability to treat complex pathology have been the two biggest barriers to adoption. Gynecologists acquiring the Aveta office suite can address a full range of pathology with unparalleled performance and cost effectiveness. The Aveta Opal Single-Use Hysteroscope is fully scalable and can quickly be converted from a pressurized saline bag to a full fluid management procedure when complex pathology is detected. The Aveta Opal Scope gives Gynecologists an economic and safe alternative for performing hysteroscopies in the office with full O.R. performance." - Matt Fratantoro, Meditrina VP of Sales and Marketing. The new Aveta devices compliment an already existing suite of innovative women's health products which include, Aveta Coral 4.6mm and Aveta Pearl 5.7mm Single-Use Hysteroscopes, Aveta Smol 2.9mm, Aveta Flex 2.9mm, and Aveta Max 3.9mm single-use resecting devices. Contact: Abbey TaylorDirector, Clinical Marketing abbeyt@meditrina-inc.com View original content: https://www.prnewswire.com/news-releases/meditrina-expands-hysteroscopic-tissue-resection-product-portfolio-with-the-release-of-the-new-aveta-office-suite-301328890.html

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Aveta Patents

Aveta has filed 1 patent.

The 3 most popular patent topics include:

  • Cancer treatments
  • Clusters of differentiation
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/2/2019

Transcription factors, Monoclonal antibodies, Clusters of differentiation, Immunology, Cancer treatments

Application

Application Date

4/2/2019

Grant Date

Title

Related Topics

Transcription factors, Monoclonal antibodies, Clusters of differentiation, Immunology, Cancer treatments

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.